Dasatinib and Quercetin Show Promise in Improving Gait Speed in HIV-Associated Frailty
Can a New Drug Combination Help Older Adults with HIV Regain Strength?
Phase II trial of dasatinib and quercetin (D+Q) in 82 HIV+ frail/prefrail adults shows potential in improving gait speed.
A new trial tests if two drugs help older adults with HIV regain strength and walk better after years of frailty.
Antibiotics for Appendicitis: 37.8% Recurrence, 44.3% Appendectomy at 10 Years
Is Antibiotic Treatment for Appendicitis a Safe Long-Term Option?
In a 10-year follow-up of the APPAC trial, 37.8% of patients treated with antibiotics for uncomplicated appendicitis experienced recurrence,…
Nearly half of patients treated with antibiotics for appendicitis avoided surgery entirely over 10 years, though about 38% experienced a rec…
Rapid Diagnostics Align 65% of ICU Antibiotic Prescriptions with Pathogen Results
Why Are Doctors Hesitant to Trust Quick Test Results for Pneumonia?
In the INHALE RCT, 65% of ICU antibiotic prescriptions aligned with BioFire FilmArray Pneumonia Panel results.
When rapid pneumonia tests find no germs, doctors often ignore the result and keep prescribing antibiotics, risking longer hospital stays an…